What are Xeris Biopharma Holdings, Inc.'s profit margins?

Xeris Biopharma Holdings, Inc. (XERS) runs a 85.9% gross margin and a 11.4% operating margin, with a 3.8% net margin.

Where do Xeris Biopharma Holdings, Inc.'s ratios come from?

Every ratio is computed from Xeris Biopharma Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Xeris Biopharma Holdings, Inc. XERS Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	85.9%+3.7pp	85.4%+3.6pp	84.6%+3.2pp	82.2%-1.5pp	82.2%-0.7pp
Operating margin	11.4%+22.3pp	8.5%+25.9pp	3.1%+27.2pp	-4.7%+15.8pp	-10.9%+15.4pp
Net margin	3.8%+24.1pp	0.2%+27.2pp	-5.9%+27.8pp	-13%+19.8pp	-20.3%+17.3pp
EBITDA margin	11.8%+22.1pp	9%+25.8pp	3.5%+27.0pp	-4.2%+15.6pp	-10.3%+15.1pp
Returns
Return on assets	3.4%+17.2pp	0.2%+17.1pp	-4.5%+14.9pp	-9.6%+8.4pp	-13.8%+5.8pp
Return on invested capital	21.4%+34.4pp	15%+36.8pp	4.7%+29.1pp	-6.2%+13.1pp	-13%+11.0pp
Efficiency
Asset turnover	0.9×+0.2×	0.8×+0.2×	0.8×+0.2×	0.7×+0.2×	0.7×+0.2×
Inventory turnover	0.7×-0.1×	0.7×-0.1×	0.7×-0.1×	0.8×0.0×	0.8×0.0×
Liquidity
Current ratio	2.1×+0.4×	2.2×+0.5×	1.9×+0.1×	1.9×-0.3×	1.7×-0.7×
Quick ratio	1.5×+0.3×	1.6×+0.4×	1.3×+0.1×	1.2×-0.4×	1.2×-0.6×
Cash ratio	0.9×+0.3×	1×+0.3×	0.8×+0.1×	0.6×-0.1×	0.6×-0.2×
Leverage
Debt-to-assets	0.7×-0.2×	0.7×-0.2×	0.7×-0.1×	0.8×0.0×	0.9×+0.1×
Interest coverage	1.3×+2.0×	0.9×+2.0×	0.3×+1.8×	-0.4×+0.9×	-0.8×+0.9×
Per Share
Book value per share	$0.07+132%	$0.08+139%	-$0.00+97.5%	-$0.12+6.8%	-$0.23-253%
Valuation
Market capitalization	$1.28B+76.9%	$1.3B+158%	$1.31B+211%	$746.32M+136%	$845.13M+178%
Enterprise value	$1.42B+52.7%	$1.45B+106%	$1.48B+133%	$944.26M+78.7%	$1.06B+107%
Price / sales	4.1×+0.8×	4.5×+2.0×	4.9×+2.7×	3×+1.3×	3.8×+2.0×
EV / sales	4.5×+0.3×	5×+1.5×	5.6×+2.2×	3.8×+0.9×	4.7×+1.8×
Earnings yield	0.9%+7.2pp	0%+10.9pp	-1.2%+13.7pp	-4.3%+14.6pp	-5.3%+15.8pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Xeris Biopharma Holdings, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Xeris Biopharma Holdings, Inc.'s profit margins?: Xeris Biopharma Holdings, Inc. (XERS) runs a 85.9% gross margin and a 11.4% operating margin, with a 3.8% net margin.
Where do Xeris Biopharma Holdings, Inc.'s ratios come from?: Every ratio is computed from Xeris Biopharma Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.